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Autophagy is themajor intracellular degradationsystembywhichcytoplasmicmaterials aredelivered
to and degraded in the lysosome. However, the purpose of autophagy is not the simple elimination of
materials, but instead, autophagy serves as a dynamic recycling system that produces new building
blocks and energy for cellular renovation and homeostasis. Here we provide a multidisciplinary
review of our current understanding of autophagy’s role in metabolic adaptation, intracellular quality
control, and renovation during development and differentiation. We also explore how recent mouse
models in combination with advances in human genetics are providing key insights into how the
impairment or activation of autophagy contributes to pathogenesis of diverse diseases, from neuro-
degenerative diseases such as Parkinson disease to inflammatory disorders such as Crohn disease.All living organisms undergo continuous renovation. In humans,
cells and intracellular components are constantly remodeled and
recycled. This is, in part, in order to replace old components with
fresh, better-quality ones. However, when components are re-
placed with different types, a net change in character results.
Such ‘‘cellular renovation’’ requires synthesis of new compo-
nents but also degradation of pre-existing materials, which can
serve as building blocks.
Eukaryotic cells have two major degradation systems, the
lysosome and the proteasome. Proteasomal degradation has
high selectivity; the proteasome generally recognizes only ubiq-
uitinated substrates, which are primarily short-lived proteins. By
contrast, degradation in the lysosome does not follow such
a simple pattern. Extracellular material and plasma membrane
proteins can be delivered to lysosomes for degradation via the
endocytic pathway. Furthermore, cytosolic components and
organelles can also be delivered to the lysosome by autophagy
(Figure 1).
The lysosome is often described as a ‘‘cellular garbage can,’’
and its more positive roles in cellular renovation, particularly
those involving autophagy, have not been well appreciated. In
the 1990s, genetic studies in yeast identified a series of auto-
phagy-related (ATG) genes (Klionsky et al., 2003; Nakatogawa
et al., 2009). The results of these studies greatly increased our
understanding of the mechanism and function of autophagy. In
particular, analyses of autophagy-defective organisms have re-
vealed numerous physiological and pathological roles of auto-
phagy at both the cellular and whole-organism levels. In this
Review, we summarize the current knowledge of autophagy
and discuss the multidisciplinary function of autophagy in reno-
vation of the cell and the organism.
Mechanisms of Autophagy
Autophagy is a generic term for all pathways by which cyto-
plasmic materials are delivered to the lysosome in animal cells
or the vacuole in plant and yeast cells. There are roughly three728 Cell 147, November 11, 2011 ª2011 Elsevier Inc.classes of autophagy (Figure 1): macroautophagy, microautoph-
agy, and chaperone-mediated autophagy. Macroautophagy
uses the intermediate organelle ‘‘autophagosome.’’ An isolation
membrane (also termed phagophore) sequesters a small portion
of the cytoplasm, including soluble materials and organelles, to
form the autophagosome. The autophagosome fuses with the
lysosome to become an autolysosome and degrade the mate-
rials contained within it. Autophagosomes may fuse with endo-
somes before fusion with lysosomes.
In microautophagy, the lysosome itself engulfs small compo-
nents of the cytoplasm by inward invagination of the lysosomal
membrane (Figure 1). Membrane dynamics during microautoph-
agy may be quite similar or identical to that of endosomal sorting
complex required for transport (ESCRT)-dependent multivesicu-
lar body (MVB) formation, which occurs in the late endosome. In
fact, significant amounts of cytosolic proteins are incorporated
into the endosomal lumen during MVB formation both in bulk
and selectively (Sahu et al., 2011).
The third type of autophagy is chaperone-mediated auto-
phagy. This class does not involve membrane reorganization;
instead, substrate proteins directly translocate across the lyso-
somal membrane during chaperone-mediated autophagy
(Figure 1). The chaperone protein Hsc70 (heat shock cognate
70) and cochaperones specifically recognize cytosolic proteins
that contain a KFERQ-like pentapeptide (Orenstein and Cuervo,
2010). The transmembrane protein Lamp-2A, which is an isoform
of Lamp-2, acts as a receptor on the lysosome, and unfolded
proteins are delivered into the lysosomal lumen through a multi-
meric translocation complex.
Macroautophagy is thought to be themajor type of autophagy,
and it has been studied most extensively compared to microau-
tophagy and chaperone-mediated autophagy. Therefore, herein
we refer to macroautophagy simply as ‘‘autophagy.’’
Autophagy is highly inducible, with starvation and other
stresses rapidly increasing the number of autophagosomes.
Autophagosomes are generated on or in close proximity to the
Figure 1. Different Types of Autophagy
Macroautophagy: A portion of cytoplasm,
including organelles, is enclosed by an isolation
membrane (also called phagophore) to form an
autophagosome. The outer membrane of the
autophagosome fuses with the lysosome, and the
internal material is degraded in the autolysosome.
Microautophagy: Small pieces of the cytoplasm
are directly engulfed by inward invagination of the
lysosomal or late endosomal membrane.
Chaperone-mediated autophagy: Substrate
proteins containing a KFERQ-like pentapeptide
sequence are first recognized by cytosolic Hsc70
and cochaperones. Then they are translocated
into the lysosomal lumen after binding with lyso-
somal Lamp-2A.
After all three types of autophagy, the resultant
degradation products can be used for different
purposes, such as new protein synthesis, energy
production, and gluconeogenesis.endoplasmic reticulum (ER) (Figure 2) (Mizushima et al., 2011;
Tooze and Yoshimori, 2010). However, it remains unclear
whether the ER membrane is directly used for autophagosome
formation. Recent studies suggest that additional membranes
derived from the Golgi complex, the mitochondria, and the
plasma membrane also contribute to autophagosome formation
(Hailey et al., 2010; Mizushima et al., 2011; Ravikumar et al.,
2010; Tooze and Yoshimori, 2010). Thus, autophagosome
formation likely involves multiple, complex processes.
Multiple Atg proteins govern autophagosome formation.
Among the 35 Atg proteins thus far identified in yeast, Atg1–10,
12–14, 16, and 18 are the ‘‘core Atg proteins’’ (Nakatogawa
et al., 2009). These proteins are required for autophagosome
formation, in addition to Atg17, 29, and 31. The core Atg
proteins are shared by other autophagy-related pathways,
such as pexophagy (autophagic degradation of the peroxi-
some) and the cytoplasm-to-vacuole targeting pathway, which
have been discussed in more detail in other reviews (Chen
and Klionsky, 2011; Nakatogawa et al., 2009; Youle and
Narendra, 2011).Cell 147, NThe core Atg proteins are highly
conserved in other eukaryotes, including
mammals, and they act in a similar hierar-
chical manner in yeast and mammals
(Itakura and Mizushima, 2010; Suzuki
et al., 2007). Figure 2 summarizes their
functional steps in mammalian cells, and
more details for this process are
described extensively elsewhere (Chen
and Klionsky, 2011; Mizushima et al.,
2011; Nakatogawa et al., 2009).
Adaptive Metabolic Response
The proteasome functions as a major
generator of amino acids under normal
nutrient-rich conditions, but autophagy’s
contribution to amino acid production
increaseswhen cells are starved (Vabulas
and Hartl, 2005). Limitation of varioustypes of nutrients, such as amino acids, growth factors, oxygen,
and energy, can induce autophagy (He and Klionsky, 2009;
Kroemer et al., 2010). Among these nutrients, starvation of
nitrogen or amino acids induces the highest levels of autophagy
in yeast and culturedmammalian cells, respectively. This is quite
reasonable because the main products of autophagy are amino
acids derived from cellular proteins. Restoration of cellular (or
local) levels of amino acids reactivates the serine/threonine
protein kinase mTORC1 (mammalian target of rapamycin
complex 1) and terminates autophagy (Yu et al., 2010). Auto-
phagy, therefore, constitutes a negative feedback loop in
response to nutrient starvation.
When yeast cells are cultured in nitrogen-free medium, auto-
phagy-deficient cells rapidly decrease intracellular amino acid
levels (Onodera and Ohsumi, 2005) and lose their viability
(Tsukada and Ohsumi, 1993). Similarly, mice with systemic
deletion of Atg3 (Sou et al., 2008), Atg5 (Kuma et al., 2004),
and Atg7 (Komatsu et al., 2005) die immediately after birth and
show reduced amino acid levels in tissues and plasma during
the neonatal starvation period. Thus, enhanced degradation ofovember 11, 2011 ª2011 Elsevier Inc. 729
Figure 2. Autophagosome Formation and
Atg Proteins in Mammalian Cells
mTOR complex 1 (mTORC1) suppresses the
ULK1 (Atg1 homolog) complex under nutrient-rich
conditions. Upon autophagy induction, the ULK1
complex (including ULK1, Atg13, FIP200, and
Atg101) is activated and translocates to a certain
domain of the endoplasmic reticulum (ER). Once in
the ER, the ULK1 complex regulates the class III
phosphatidylinositol (PtdIns) 3-kinase complex
(including Beclin 1, Atg14(L)/barkor, Vps15,
Vps34, and Ambra1), and this regulation is
promoted by RalB and an Exo84-containing
exocyst complex. Recruitment of Beclin 1 to the
PtdIns3-kinase complex is also sensitive to
starvation; Beclin 1 forms a complex with ER-
associated Bcl-2 under nutrient-rich conditions
and is released upon phosphorylation of Bcl-2 by
JNK1. Atg9L, a multimembrane-spanning protein,
is also involved in an early stage of autophago-
some formation (Atg9L is recruited likely on vesi-
cles). Formation of PtdIns(3)P recruits double
FYVE-containing protein 1 (DFCP1) and promotes
the formation of the omegasome, from which
autophagosomes appear to be generated.
Other PtdIns(3)P-binding WIPI proteins (WD-
repeat protein interacting with phosphoinoside)
(Atg18 homologs) are also crucial for the
maturation of the omegasome/isolation mem-
brane. The Atg12–Atg5–Atg16L1 complex and
the LC3 (Atg8 homolog)–phosphatidylethanol-
amine (PE) conjugate play important roles in the
elongation and closure of the isolation membrane.
The Atg12–Atg5–Atg16L1 complex is also
required for formation of the covalent bond
between LC3 and PE.self-components by autophagy is a critical survival response
against starvation conditions.
An important question is, how do cells use these amino acids
produced by autophagy (Figures 1 and 3)? Initial induction of
autophagy is very rapid and occurs before energy fuels are
completely exhausted. For instance, mice starved for 24 hr
show increased autophagy in many tissues, but they still have
sufficient lipids (glycogen may be consumed during the first
day). Therefore, it is unlikely that autophagy simply supplies
energy in these settings. In fact, several studies have suggested
that autophagy-derived amino acids are used to synthesize
proteins essential for starvation adaptation.
Protein anabolism is generally downregulated in starved
cells, but synthesis of certain types of proteins continues or
is even upregulated during starvation. These include vacuolar/
lysosomal enzymes, respiratory chain proteins, antioxidant
enzymes, and proteins involved in pathways of amino acid
biosynthesis (Onodera and Ohsumi, 2005; Suzuki et al.,
2011). Autophagy-deficient yeast cells fail to synthesize these
proteins during starvation. As a result, these mutants loose
respiratory function and accumulate higher levels of reactive
oxygen species, which further decreases their mitochondrial
DNA content (Suzuki et al., 2011). These appear to be the major730 Cell 147, November 11, 2011 ª2011 Elsevier Inc.mechanisms that rapidly kill autophagy-deficient yeast cells
during nitrogen limitation.
Nonetheless, autophagy seems to be an important energy
generator in certain settings. Amino acids can be converted
into intermediates of the tricarboxylic acid (TCA) cycle and
thus contribute to ATP production. Metabolome analysis of
Ras-expressing cancer cells shows that autophagy is important
for maintenance of TCA cycle metabolites (Guo et al., 2011). It is
interesting that citrate, aconitate, and isocitrate, which are solely
produced in mitochondria, are specifically reduced, suggesting
that autophagy could be important not only for providing TCA
metabolites but also for quality control of mitochondria. In
addition, breakdown of lipid droplets by autophagy (lipophagy)
may also account for its energy-producing role, especially in
the liver (Singh et al., 2009).
Finally, amino acids are thought to be an important source for
gluconeogenesis in the liver. In fact, when Atg7 is deleted specif-
ically in the liver, the mutant mice show reduced levels of blood
glucose and amino acids after 24 hr of starvation (Ezaki et al.,
2011). This finding suggests that amino acids generated inside
the liver are used for gluconeogenesis and maintenance of the
plasma pool of amino acids. How much autophagy contributes
to overall gluconeogenesis is still unknown.
Figure 3. Nonselective and Selective Auto-
phagy
(A) Upon nutrient deprivation, autophagy catabo-
lizes cytoplasmic components nonselectively into
building blocks, such as amino acids. A defect in
this process causes amino acid insufficiency,
which impairs protein synthesis for adaptation to
starvation and energy production for cell survival.
Autophagy also occurs constitutively at low levels
even under nutrient-rich conditions and mediates
global turnover of cytoplasmic materials.
(B) The LC3-binding protein p62 is a specific
substrate for autophagy. Defective autophagy is
usually accompanied by extensive accumulation
of p62. This accumulation enhances p62’s func-
tion as a scaffold protein in several signaling
pathways, such as NF-kB signaling, apoptosis,
and Nrf2 activation. p62 has a UBA domain
through which it can mediate sequestration of
ubiquitinated proteins into autophagosomes.
(C) In response to the loss of the mitochondrial
membrane potential, Parkin translocates to
damaged mitochondria in a PINK1-dependent
manner and then ubiquitinates outer membrane
proteins, which then induce mitophagy. The
involvement of p62 as an adaptor is controversial.
Mutants of Parkin and PINK1, which are associ-
ated with Parkinson disease, are unable to induce
mitophagy, suggesting that the remaining
damaged mitochondria have a role in the patho-
genesis of Parkinson disease.
(D) Invading bacteria in the cytosol and/or ruptured endosomal membranes are ubiquitinated, and autophagic receptors including p62, NDP52, and
optineurin mediate autophagic sequestration of the microbes to restrict their growth.Intracellular Quality Control by Nonselective
and Selective Autophagy
Approximately 1%–1.5% of cellular proteins are catabolized per
hour by autophagy, even under nutrient-rich conditions in the
liver. It is unclear how much basal autophagy contributes to
macromolecule synthesis and energy production in the steady
state by supplying amino acids, glucose, and free fatty acids.
Nevertheless, basal autophagy acts as the quality-control
machinery for cytoplasmic components, and it is crucial for
homeostasis of various postmitotic cells, such as neurons and
hepatocytes. Although this quality control could be partially
achieved by nonselective autophagy, increasing evidence indi-
cates that ‘‘selective’’ autophagy degrades specific proteins,
organelles, and invading bacteria (Figure 3). Selective autophagy
occurs constitutively and can also be induced in response to
cellular stresses.
Selective Degradation of p62
One of the best characterized substrates of selective autophagy
is p62, which is also known as sequestosome 1/SQSTM1. p62 is
an ubiquitously expressed cellular protein, which is conserved in
animals but not in plants and fungi. p62 directly interacts with
LC3 (microtubule-associated protein light chain 3) on the isola-
tion membrane through the LC3-interacting region (Figure 3).
(LC3 is the mammalian homolog of Atg8 in yeast.) Subsequently,
p62 is incorporated into the autophagosome and then degraded
(Johansen and Lamark, 2011; Weidberg et al., 2011).
Impairment of autophagy is accompanied by accumulation
of p62. This leads to the formation of large aggregates, which
include p62 and ubiquitin (Komatsu et al., 2007a). Similar
inclusion bodies with p62 and ubiquitin have been identified in
various neurodegenerative diseases, including Alzheimerdisease, Parkinson disease, and amyotrophic lateral sclerosis;
liver disorders, including alcoholic hepatitis and steatohepatitis;
and cancers, including malignant glioma and hepatocellular
carcinoma (Zatloukal et al., 2002). When Atg7 is disrupted in
livers and brains of mice, p62-positive aggregates are observed
in their hepatocytes and neurons, respectively. Interestingly,
these aggregates, as well those in human hepatocellular carci-
noma cells, are completely dispersed by the additional loss of
p62 (Inami et al., 2011; Komatsu et al., 2007a). These findings
implicate p62 in the formation of disease-related inclusion
bodies (Figure 3).
p62 functions as a signaling hub that may determine whether
cells survive by activating the TNF receptor-associated factor 6
(TRAF6)–NF-kB pathway or die by facilitating the aggregation of
caspase-8 and downstream effector caspases (Moscat and
Diaz-Meco, 2009). On the other hand, p62 interacts with the
Nrf2-binding site on Keap1, a component of Cullin3-type ubiqui-
tin ligase for Nrf2. This interaction stabilizes Nrf2 and activates
the transcription of Nrf2 target genes, including a battery of anti-
oxidant proteins (Komatsu et al., 2010; Lau et al., 2010). It is thus
possible that excess accumulation or aggregation of p62 leads
to hyperactivation of these signaling pathways (Figure 3).
Selective Degradation of Ubiquitinated Cargos
Almost all tissues with defective autophagy display an accumu-
lation of polyubiquitinated proteins (Mizushima and Levine,
2010). Loss of autophagy is thought to delay global turnover of
cytoplasmic components (Hara et al., 2006) and impair the
degradation of substrates destined for the proteasome (Korol-
chuk et al., 2009). These effects could partially explain the accu-
mulation of misfolded and unfolded proteins followed by the
formation of inclusion bodies.Cell 147, November 11, 2011 ª2011 Elsevier Inc. 731
However, p62 has a ubiquitin-associated (UBA) domain. Thus,
it has been proposed that p62 may be an autophagy receptor for
degrading ubiquitinated cargos, including ubiquitinated aggre-
gates, damaged mitochondria, ubiquitinated midbody rings,
ubiquitin-tagged peroxisomes, ubiquitinated microbes, ribo-
somal proteins, and virus capsid proteins (Johansen and
Lamark, 2011; Weidberg et al., 2011) (Figure 3). p62 and other
adaptor proteins, such as NDP52 (Thurston et al., 2009) and op-
tineurin (Wild et al., 2011), mediate the degradation of invading
microbes via their interaction with ubiquitination (Figure 3). This
selective autophagy could be regulated by posttranslational
modification of the adaptors. For instance, TANK-binding kinase
(TBK1) phosphorylates optineurin, which enhances its binding
affinity to LC3 and thereby suppresses growth of invading
microbes (Wild et al., 2011).
Although a large number of studies suggest that p62 acts as an
ubiquitin adaptor, it is still unknown whether soluble ubiquiti-
nated proteins are also degraded through p62 binding. A mass
spectrometric analysis clearly demonstrated that ubiquitinated
proteins in autophagy-deficient livers and brains do not show
any linkage specificity, indicating that specific polyubiquitin
chain linkage is not the decisive signal for autophagic degrada-
tion (Riley et al., 2010). The simultaneous knockout of either
p62 or Nrf2 completely suppresses the increase in ubiquitin
conjugates in Atg7-deficient liver and brain (Riley et al., 2010).
Therefore, the accumulation of ubiquitinated proteins in tissues
defective in autophagy might be attributed to p62-mediated
activation of Nrf2, resulting in global transcriptional changes to
ubiquitin-associated genes. Further studies will be needed to
elucidate more precisely the mechanism of degradation of ubiq-
uitinated proteins by autophagy.
Degradation of Damaged Mitochondria: Implications
for the Pathogenesis of Parkinson Disease
Recent studies have described the molecular mechanism by
which damaged mitochondria are selectively targeted for auto-
phagy, and these studies also suggest that the defects in this
process underlie familial Parkinson disease (Youle and Naren-
dra, 2011). PINK1, a mitochondrial kinase, and Parkin, an E3
ubiquitin ligase, have been genetically linked to both Parkinson
disease and a pathway that prevents progressive mitochondrial
damage and dysfunction. When mitochondria are damaged and
depolarized, PINK1 becomes stabilized and recruits Parkin to
the damaged mitochondria (Matsuda et al., 2010; Narendra
et al., 2008; Narendra et al., 2010a; Vives-Bauza et al., 2010).
Parkin ubiquitinates various mitochondrial outer membrane
proteins, which could trigger mitophagy. However, the precise
substrate of Parkin, which is essential for mitophagy, is still
unknown (Figure 3). Of note, mutations in PINK1 and Parkin,
which are associated with Parkinson disease, are known to
impair mitophagy (Matsuda et al., 2010; Narendra et al., 2008,
2010a; Vives-Bauza et al., 2010), suggesting that there is a link
between defective mitophagy and Parkinson disease. Accumu-
lation of damaged mitochondria would cause oxidative stress
and loss of neuronal cells.
Nevertheless, many questions remain about mitophagy and
Parkin. First, it is unknown how the autophagosome recognizes
these ubiquitinated mitochondria. Although p62 has been impli-
cated in this recognition process, elimination of mitochondria732 Cell 147, November 11, 2011 ª2011 Elsevier Inc.occurs normally in p62-deficient cells (Narendra et al., 2010b;
Okatsu et al., 2010). p62 seems to be required for the clustering
of depolarized mitochondria in the perinuclear region. The role of
other mitochondrial adaptor proteins such as Nix remains
unknown (Novak et al., 2010). Second, Parkin appears to func-
tion in other degradative processes besides mitophagy. Parkin
can induce degradation of a broad range of mitochondrial outer
membrane proteins, such as mitofusin 1/2 and Tom20 (Chan
et al., 2011; Tanaka et al., 2010; Yoshii et al., 2011), which may
also be important for mitochondrial quality control. Third, in
contrast to in vitro studies, a recent in vivo study showed that
depolarized mitochondria do not recruit Parkin in dopamine
neurons (Sterky et al., 2011). Thus, Parkin seems to havemultiple
functions in mitochondrial quality control and neuronal cell
survival. More studies are needed to fully understand the physi-
ological and pathological role of this protein.
Renovation during Differentiation and Development
Development and differentiation processes are often accompa-
nied by drastic cellular and tissue remodeling, which requires
enhanced degradation. Autophagy can ‘‘kill two birds with one
stone’’ during this remodeling; it eliminates pre-existing mate-
rials and provides support for the subsequent creation of new
components (Mizushima and Levine, 2010). For example, auto-
phagy has been shown to be required for formation of spores
in yeast (Tsukada and Ohsumi, 1993) and dauer larvae inCaeno-
rhabditis elegans (Mele´ndez et al., 2003), both of which are
triggered by starvation to sustain the organism during adverse
conditions. Autophagy also plays a crucial role in insect meta-
morphosis (Ryoo and Baehrecke, 2010). It is possible that
autophagy-derived amino acids can be used as essential
building blocks in these processes.
The most dramatic cellular renovation may occur shortly after
fertilization. Maternal proteins and messenger RNAs (mRNAs)
are extensively degraded while new proteins encoded by the
zygotic genome are synthesized. In mammals, fertilization
induces massive autophagy, which plays an essential role in
early embryogenesis (Tsukamoto et al., 2008) (Figure 4). Nutrient
availability may be limited in embryos until implantation, and
autophagy functions as amajor nutrient-providing system during
this period. In addition, autophagy in early embryos is essential
for selective elimination of paternal mitochondria in C. elegans.
This could be a key mechanism underlying maternal inheritance
of mitochondrial DNA and may be conserved in mammals (Sato
and Sato, 2011; Al Rawi et al., 2011).
Atg3/ (Sou et al., 2008),Atg5/ (Kuma et al., 2004),Atg7/
(Komatsu et al., 2005), Atg9/ (Saitoh et al., 2009), and
Atg16L1/ (Saitoh et al., 2008) mice die shortly after birth
without apparent anatomical abnormalities. However, tissue-
specific gene-targeting studies have later revealed that auto-
phagy functions in several specific lineages of differentiation,
such as adipocytes, erythrocytes, T cells, and B-1a cells
(Figure 4). Autophagy may play an important role in complete
or partial elimination of mitochondria during these processes
(Mizushima and Levine, 2010). In a separate mechanism,
autophagy in thymic epithelial cells could be involved in the
establishment of self-tolerance of T cells; specifically, autophagy
fine tunes epithelial cells’ presentation of self-antigens to
Figure 4. Physiological and Pathological Roles of Autophagy
Although this figure is illustrated for a human, these data have been obtained from both mouse and human. XMEA: X-linked myopathy with excess autophagy,
UCMD: Ullrich congenital muscular disorder.thymocytes, which leads to the elimination of some populations
of self-reactive T cells (Nedjic et al., 2008) (Figure 4).
Tissue Homeostasis and Renovation
in Health and Disease
Liver
Regardless of the nutritional situation, basal autophagy metabo-
lizes cytoplasmic components to prevent accumulation of
degenerated proteins and organelles (Figure 4). Loss of Atg7 in
mouse hepatocytes causes marked accumulation of swollen
and deformed mitochondria and the appearance of concentric
membranous structures consisting of ER. In addition, loss of
Atg7 leads to an increased number of peroxisomes and lipid
droplets, as well as the formation of protein aggregates positive
for p62 and ubiquitin (Komatsu et al., 2005). These mutant mice
exhibit severe hepatomegaly (i.e., an enlarged liver) and hepato-
cytic hypertrophy, followed by hepatitis (Komatsu et al., 2005).
This defective intracellular quality control in the liver appears to
be most severe among various types of tissue-specific deletions
of autophagy.
What directly causes these abnormalities? Simultaneous dele-
tion of either p62 or Nrf2 dramatically attenuates the liver injury
resulting from autophagy deficiency (Komatsu et al., 2007a,
2010). These results suggest that persistent activation of Nrf2,due to impaired turnover of p62, canaccount formost of thepath-
ogenic changes seen in the livers of autophagy-deficient mice.
Autophagy could be a therapeutic target of a1-antitrypsin defi-
ciency. In affected children, misfolded mutant antitrypsin protein
accumulates in the liver and causes liver damage and cirrhosis.
Both proteasomal and autophagic pathways have been impli-
cated in degradation of the mutant protein. A recent study
demonstrated that an autophagy-activating drug, carbamaze-
pine, decreases the amount of the mutant protein and amelio-
rates hepatic fibrosis in a mouse model of a1-antitrypsin
deficiency (Hidvegi et al., 2010). Such therapeutic strategies
could be applied to a wide range of protein conformation disor-
ders, such as Huntington and prion diseases.
Brain
Even under prolonged fasting conditions, the number of auto-
phagosomes does not increase in nerve cells (Mizushima et al.,
2004) probably because nerve cells are supplied with nutrients
from peripheral organs. However, recent studies demonstrated
that autophagy can be induced in cortical neurons, Purkinje
cells, (Alirezaei et al., 2010), and hypothalamic neurons during
fasting (Kaushik et al., 2011). This autophagic response in the
hypothalamus induces lipophagy and upregulates agouti-
related peptide (AgRP) expression, which increases food intake
(Kaushik et al., 2011). Accordingly, deleting Atg7 specificallyCell 147, November 11, 2011 ª2011 Elsevier Inc. 733
in AgRP neurons reduces body weight and adiposity. However,
the opposite finding has been also reported; suppressing Atg7
in the hypothalamus with short-hairpin RNAs causes obesity
through the IKK-b/NF-kB pathway (Meng and Cai, 2011). Consti-
tutive suppression of autophagy from the embryonic period
versus transient suppression in the adult mice may produce
different phenotypes, or distinct types of hypothalamic neurons
have different autophagy functions.
In contrast to the rather complicated metabolic role of auto-
phagy, the importance of autophagy as a ‘‘housekeeper’’ is
easy to envision because neurons are terminally differentiated
and do not divide (Figure 4). Mice lacking autophagy in the
central nervous system exhibit neurologic deficits, such as
abnormal limb-clasping reflexes, locomotor ataxia, and lack of
motor coordination. They also display significant losses of large
pyramidal neurons in the cerebral cortex and of Purkinje cells in
the cerebellar cortex (Hara et al., 2006; Komatsu et al., 2006;
Liang et al., 2010). Polyubiquitinated proteins and p62 accumu-
late in neurons in almost all regions of autophagy-defective
brains, forming inclusion bodies whose size and number
increase with aging (Hara et al., 2006; Komatsu et al., 2006,
2007a). Furthermore, mice with autophagy disrupted specifically
in Purkinje cells exhibit progressive axonal dystrophy and
degeneration of axon terminals, followed by Purkinje cell death
and behavioral deficit. These results indicate that autophagy
plays a cell-autonomous role in axonal homeostasis (Komatsu
et al., 2007b; Nishiyama et al., 2007). Unlike the case of auto-
phagy-deficient hepatocytes, the survival of autophagy-defi-
cient neurons is restored only to a small degree by simultaneous
deletion of p62, even though protein aggregates completely
disappear in neuronal cells, as they do in hepatocytes (Komatsu
et al., 2007a). Thus, neither p62 accumulation nor inclusion body
formation explains the neurodegeneration and impaired neuro-
logical function of these mutant mice, and it is likely that auto-
phagy plays a more general role in the brain.
Undoubtedly, the housekeeping role of autophagy becomes
more evident when neurons are loaded with pathogenic
proteins. These proteins include aggregate-prone mutant forms
of a-synuclein that underlie Parkison disease and expanded pol-
yglutamine (polyQ)-containing proteins that are responsible for
Huntington disease and spinocerebellar ataxia (Figure 4) (Ru-
binsztein, 2006). Indeed, accumulation of autophagic vacuoles
has been demonstrated in human neurodegenerative diseases
(Lee et al., 2010; Nixon et al., 2008). To be degraded by the pro-
teasome, substrate proteins must be unfolded prior to delivery
into the narrow proteasomal chamber. However, the aggregated
proteins are usually resistant to unfolding, and moreover, polyQ
fragments could cause malfunction of the proteasome (Bence
et al., 2001). Accordingly, clearance of misfolded, aggregate-
prone proteins is highly dependent on autophagy. In fact, phar-
macologic upregulation of autophagy has been shown to be
effective in reducing neuronal aggregates and slowing the pro-
gression of neurological symptoms in animal models, such as
Huntington disease and tauopathy models (Fleming et al., 2011).
Heart
Constitutively suppressing autophagy in the heart from the
embryonic period does not initially cause an obvious phenotype
in mice, but these animals spontaneously develop cardiomy-734 Cell 147, November 11, 2011 ª2011 Elsevier Inc.opathy and die after 6 months of age (Taneike et al., 2010).
Sarcomere structure is impaired and deformed in mice, and
dysfunctional mitochondria accumulate in their cardiomyocytes.
This housekeeping role of autophagy is more clearly observed
when Atg5 is disrupted specifically in the heart by tamoxifen;
sudden ablation of the autophagic function in adult mice imme-
diately causes cardiac hypertrophy and dysfunction, accompa-
nied by the accumulation of ubiquitinated proteins (Nakai et al.,
2007). Thus, constitutive basal autophagy is critically important
for cardiac homeostasis (Figure 4).
Besides this basal role, autophagy can also be induced in the
heart by pressure overload (Nakai et al., 2007; Zhu et al., 2007).
Although the animals appear grossly normal at younger ages,
constitutive knockout of Atg5 in the heart sensitizes mice to
cardiac dysfunction and dilatation following pressure overload
(Nakai et al., 2007). This suggests that autophagy induction in
the heart could be an adaptive response to hemodynamic stress.
Paradoxically, heterozygous deletion of Beclin 1, which partially
reduces autophagic activity, improves cardiac function upon
pressure overload (Zhu et al., 2007). This suggests that fully acti-
vated autophagy could be a maladaptive response, whereas
partial, but not complete, suppression of autophagy may be
beneficial. Consistent with this hypothesis, partial suppression
of autophagy with histone deacetylase (HDAC) inhibitors amelio-
rates pressure overload-induced cardiac hypertrophy in mice
(Cao et al., 2011).
Skeletal Muscle
Mice with Atg5 (Raben et al., 2008) or Atg7 (Masiero et al., 2009)
disrupted specifically in the skeletal muscle display age-depen-
dent muscle atrophy. Like autophagy-defective cardiomyo-
cytes, their muscle cells exhibit disorganized sarcomeres and
the accumulation of p62, ubiquitinated proteins, and deformed
mitochondria, confirming the homeostatic role of autophagy in
skeletal muscle (Figure 4). Muscle atrophy can be induced by
fasting and denervation, but autophagy does not appear to be
involved in both of these atrophy processes. Instead, suppres-
sion of autophagy exacerbates fasting- and denervation-
induced muscle atrophy (Masiero et al., 2009).
Autophagosomes have been frequently recognized as patho-
gnomonic morphological hallmarks of numerous neuromuscular
disorders, including Danon disease, X-linked myopathy with
excess autophagy (XMEA), and lysosomal storage diseases
(Figure 4) (Malicdan et al., 2008). Danon disease with an X-linked
dominant inheritance pattern is characterized by cardiomyop-
athy, myopathy, and variable mental retardation. It is caused
by mutations in the coding sequence of Lamp-2, which affects
lysosomal function or autophagosome-lysosome fusion (Nishino
et al., 2000). Patients with XMEA show similar morphological
features to those with Danon disease, implying abnormality of
lysosomal function (Malicdan et al., 2008).
Autophagy is also implicated in the pathogenesis of lysosomal
storage diseases. Deleting acid alpha-glucosidase in mice is
an animal model of Pompe disease, in which glycogen accu-
mulation in lysosomes causes skeletal myopathy and cardiomy-
opathy. Autophagy may be one route by which cytosolic
glycogen is delivered to the lysosome. Suppression of auto-
phagy in the skeletal muscle of this mouse model reduces the
glycogen content, and there is a remarkable additive effect
with enzyme-replacement therapy (administration of recombi-
nant human acid alpha-glucosidase) (Raben et al., 2010). This
raises the possibility that suppression of autophagy could be
a new therapeutic approach for Pompe disease.
Bethlem myopathy and Ullrich congenital muscular disorder
are caused by mutations in any of the three genes coding for
the extracellular matrix protein collagen-6. Mice deficient in
collagen-6 (col6a1) provide a model for these diseases. Loss of
collagen-6 leads to an activation of Akt, which decreases auto-
phagy through inactivation of the transcription factor FoxO3
and activation of mTOR (Grumati et al., 2010). Consequently,
structurally altered organelles, including mitochondria and
sarcoplasmic reticulum, accumulate in the muscles of the
col6a1 knockout mice, causing cell toxicity and death. Of note,
induction of autophagy by treatment with a low-protein diet, ra-
pamycin, or cyclosporin A clears the abnormal organelles and
ameliorates the dystrophic phenotypes in col6a1 knockout
mice (Grumati et al., 2010).
Intestine
Crohn disease is one of the most common inflammatory
diseases, and a link to the innate immune system has been
established for this disease. However, several studies have iden-
tified an unexpected association between Crohn disease and
a single-nucleotide polymorphism (SNP) of Atg16L1 (threonine
300 is replaced by alanine) (Hampe et al., 2007; Rioux et al.,
2007; The Wellcome Trust Case Control Consortium, 2007). To
date, this is the only case in which a SNP in the core ATG genes
has been associated with a human disease, and the finding high-
lights a potential importance of autophagy in intestinal biology
(Figure 4). Later studies also identified an association between
Crohn disease and IRGM (immunity-related GTPase family, M),
which has also been implicated in autophagy against intracel-
lular pathogens (McCarroll et al., 2008; Parkes et al., 2007).
However, the role of autophagy in the intestine and the patho-
genesis of Crohn disease are not simple. Threonine 300 is
located in the C-terminal WD repeat domain in Atg16L1.
Because yeast Atg16 lacks the entire WD repeat domain, the
N-terminal half of Atg16L1 may be sufficient for conventional
autophagy, and the role of the WD domain remains unknown.
One study suggested that the Atg16L1T300Amutant is defective
in autophagic sequestration of intracellular bacteria but not in
canonical autophagy (Kuballa et al., 2008). Another study,
however, suggested that this mutant has intact activity in both
canonical autophagy and antibacterial autophagy (Fujita et al.,
2009). More experiments are required to determine how the
T300A replacement modifies the molecular function of Atg16L1.
Furthermore, evidence from in vivo studies has suggested that
autophagy or ATG genes have a role in maintaining the normal
function of Paneth cells (Cadwell et al., 2008, 2010). Although
complete systemic deletion of Atg16L1 causes neonatal lethality
(Saitoh et al., 2008), Atg16L1 hypomorphic mice, which express
a very low level of Atg16L1, are viable and grossly normal.
However, these mice exhibit structurally abnormal Paneth cells
with cytoplasmic lysozyme staining. In addition, Paneth cells
normally possess granules containing antimicrobial peptides,
but in the Atg16L1 hypomorphic mice, these granules are
disorganized (Cadwell et al., 2008). Crohn disease patients
homozygous for the ATG16L1 risk allele (T300A) show similarPaneth cell abnormalities as mice with Atg5 knocked out specif-
ically in the intestine. Furthermore, pathology of the Paneth cell
can be dependent on viral infection and probably other environ-
mental factors, as well (Cadwell et al., 2010). Thus, autophagy
appears to be important for the integrity of vesicle secretion in
Paneth cells.
In addition to these cell-intrinsic mechanisms, a link between
autophagy and the immune system can also contribute to the
pathogenesis of Crohn disease. This link occurs through a direct
interaction between Atg16L1 and NOD2/CARD15 (which has the
strongest association with Crohn disease) in the bacterial
sensing pathway (Travassos et al., 2010) and through the regula-
tion of inflammatory cytokine production from macrophages
(Saitoh et al., 2008).
Pancreas
Constitutive suppression of autophagic activity in pancreatic
b cells causes reduction in b cell mass, hypoinsulinemia, and
the accumulation of ubiquitinated proteins, p62, and deformed
organelles (i.e., mitochondria and ER) (Ebato et al., 2008; Jung
et al., 2008). Thus, basal autophagy is important for maintenance
of b cell volume and function (Figure 4). Furthermore, autophagy
can be activated in b cells by free fatty acids. This process is
considered to be an adaptive response, particularly in the pres-
ence of insulin resistance (Ebato et al., 2008).
By contrast, autophagy may exert a detrimental effect in the
exocrine pancreas. Mice with Atg5 deleted specifically in acinar
cells grow normally and show no significant abnormalities of
pancreatic histology and blood biochemistry, suggesting that
basal autophagy may be dispensable in pancreatic acinar cells
(Hashimoto et al., 2008). However, these mice are resistant to
acute pancreatitis induced by cerulein (a cholecystokinin
analog). Inappropriate activation of trypsinogen inside acinar
cells, which is a cause of acute pancreatitis, is reduced in the
absence of autophagy (Hashimoto et al., 2008). Together with
the evidence that autophagosomes/autolysosomes accumulate
in acute pancreatitis (Hashimoto et al., 2008; Mareninova et al.,
2009), these data suggest that trypsinogen could be delivered
to the lysosome by autophagy to become the active form in path-
ogenic settings (Figure 4). However, another study reported an
opposite result in which blocking lysosomal function contributed
to the pathogenesis of pancreatitis (Fortunato et al., 2009).
This apparent discrepancy could be resolved by the findings of
future studies. Activity of cathepsin L, which can completely
degrade trypsinogen, is severely reduced in pancreatitis. In
contrast, activity of cathepsin B, which converts trypsinogen
into active trypsin, seems to be relatively spared in the zymogen
granule-containing fraction (Mareninova et al., 2009). This
cathepsin ‘‘unbalance’’ could also explain why acute pancrea-
titis occurs only under special conditions and not following usual
starvation, during which trypsinogen should be completely di-
gested even if delivered to the lysosome.
Kidney
Podocytes (visceral epithelial cells) wrap around the capillaries
of the glomerulus in the kidney, which help to filter blood. Podo-
cytes display a high level of basal autophagy, implying that they
might rely heavily on constitutive autophagic activity for their
homeostasis (Mizushima et al., 2004). Consistent with this,
podocyte-specific deletion of Atg5 causes glomerulosclerosisCell 147, November 11, 2011 ª2011 Elsevier Inc. 735
with an accumulation of intracellular ubiquitinated proteins in
aging mice (Hartleben et al., 2010). In addition, these mice
show increased susceptibility to proteinuric renal diseases
caused by puromycin aminonucleoside and adriamycin, which
normally upregulate autophagic activity in intact podocytes (Har-
tleben et al., 2010).
Autophagy also occurs in renal tubules. Mice with Atg5 specif-
ically deleted in the proximal tubules exhibit the accumulation of
misfolded proteins and deformed organelles, and they are
susceptible to ischemia-reperfusion injury (Kimura et al., 2011).
These studies suggest that both podocytes and tubular cells
require basal autophagy for homeostasis and adaptive auto-
phagy to cope with stresses (Figure 4).
Lung
Deletion of Atg7 in bronchial epithelial cells leads to the accumu-
lation of p62 and activation of Nrf2. This results in hyper-respon-
siveness to cholinergic stimuli, suggesting that autophagy has
a homeostatic role in lung epithelia (Figure 4) (Inoue et al., 2011).
Autophagy also seems to be involved in the development of
pulmonary diseases. Cystic fibrosis is a common recessive
genetic disease, which is caused by a mutation in cystic fibrosis
transmembrane conductance regulator (CFTR), a cAMP-depen-
dent chloride channel. A single amino acid deletion, called
DF508-CFTR, causes the protein tomisfold, leading to premature
degradationoraggregation.Asa result, secretoryorgans, suchas
the lung and pancreas, are affected. Airway epithelial cells from
cystic fibrosis patients and mouse models of the disease have
reduced autophagic activity likely because Beclin 1 is seques-
tered into cytoplasmic aggregates (Luciani et al., 2010). Impaired
autophagy could be pathogenic because restoration of Beclin 1
expression rescues the cystic fibrosis phenotype in mice.
Bone
Although the physiological roles of autophagy in bone remain
largely unknown, autophagy may be related to the development
of bone diseases. Paget disease of bone is a chronic and meta-
bolic bone disorder that is characterized by increased bone turn-
over within discrete lesions throughout the skeleton. Mutations
in p62, which is a substrate of selective autophagy, have been
frequently identified in Paget disease of bone; these mutations
are predominantly in the UBA domain of p62 (Goode and Lay-
field, 2010). The p62mutations cause increased osteoclastogen-
esis by activating TRAF6–NF-kB signaling (Figure 3) (Goode and
Layfield, 2010). This suggests that the regulation of p62 levels by
autophagy is important for bone formation.
Inclusion body myopathy associated with Paget disease of
bone and frontotemporal dementia (IBMPFD) is a rare inherited
disorder that exhibits multiple phenotypic features, including
myopathy with rimmed vacuoles and bone disease. This
disorder is caused by a mutation in valosin-containing protein
(VCP)/p97. Although VCP has multiple functions, such as in
ER-associated degradation, it also participates in the maturation
of the autophagosome, and immature autophagosomes accu-
mulate in IBMPFD muscles and IBMPFD mutant-expressing
mice (Ju et al., 2009).
Tumor Formation and Progression
A tumor-suppressive role of autophagy has been implicated and
appears to be particularly important in the liver. Spontaneous736 Cell 147, November 11, 2011 ª2011 Elsevier Inc.benign tumorigenesis is observed in the livers of mice with
systemic mosaic deletion of Atg5 (i.e., the Atg5 gene is deleted
in only some populations of cells in various tissues) or with
Atg7 specifically disrupted in hepatocytes (Inami et al., 2011;
Takamura et al., 2011). Interestingly, tumors are not formed in
other organs in the Atg5mosaically deletedmice. Enlargedmito-
chondria, with at least partially impaired functions, accumulate in
hepatocytes of Atg5- or Atg7-deficient mice (Inami et al., 2011;
Takamura et al., 2011). As previously demonstrated in other
cell types (Karantza-Wadsworth et al., 2007; Mathew et al.,
2007), the oxidative stress responses and genomic damage
responses are enhanced in autophagy-deficient livers. Accumu-
lation of p62, at least partially, contributes to tumor growth
because the size of the liver tumors in Atg7/ mice is reduced
by the simultaneous deletion of p62 (Takamura et al., 2011).
This may be due to dysregulation of NF-kB signaling (Mathew
et al., 2009) and persistent activation of Nrf2 (DeNicola et al.,
2011). Mice heterozygous for Beclin 1, who have significantly
less autophagic activity, are also prone to cancer. These animals
develop spontaneous tumors, including hepatocellular carci-
noma, and they have an increased incidence of liver tumors after
infection with hepatitis B virus (Qu et al., 2003; Yue et al., 2003).
Although autophagy functions as a tumor suppressor in nontu-
mor cells or the early stages of tumor cell development, auto-
phagy becomes important for cancer cell survival once tumors
are established. Cancer cells have an increased metabolic
demand (in terms of both energy source and building blocks)
for proliferation, and they often need to grow under hypoxic
conditions until angiogenesis is sufficiently established. There-
fore, cancer cells, particularly those with Ras mutations, rely
heavily on autophagy and are ‘‘addictive’’ to autophagy (Yang
et al., 2011). Growth defects caused by autophagy suppression
have also been observed in Myc-induced lymphoma and poly-
oma middle T-induced mammary tumor cells (Maclean et al.,
2008; Wei et al., 2011). Autophagy can also be an adaptive
response to chemotherapy (Amaravadi et al., 2007). However,
the involvement of Ras is not simple; Ras-induced autophagy
contributes to tumor suppression by inducing autophagic cell
death and senescence (Elgendy et al., 2011; Young et al.,
2009). The Ras-mediated autophagy might have different roles
in tumor growth dependent on cellular context or cancer stage.
Given the role of autophagy in tumor progression, autophagy
suppression could be a strategy for cancer treatment (Amara-
vadi et al., 2011; Janku et al., 2011). In fact, tumor cell death
can be induced in mouse models using drugs that inhibit auto-
phagy (e.g., the lysosome-inhibitory reagent chloroquine) in
combination with conventional chemotherapy (Amaravadi
et al., 2007; Degtyarev et al., 2008; Yang et al., 2011). After these
basic studies were published, >20 clinical trials of autophagy-in-
hibiting drugs (i.e., hydroxychloroquine and chloroquine) were
initiated (http://clinicaltrials.gov/ct2/results?term=autophagy)
(Amaravadi et al., 2011).
One concern could be that, if autophagy is suppressed
systemically, it may cause many adverse side effects because
autophagy is critically important in almost all tissues. However,
thus far, hydroxychloroquine seems to be tolerated (Amaravadi
et al., 2011). It is possible that only a partial reduction in autopha-
gic activity, which may show no apparent effect on normal cells,
could be beneficial in human diseases. Thismay be analogous to
the effect of proteasome inhibitors: malignant myeloma cells that
secrete immunoglobulin are more dependent on proteasomal
degradation than normal cells, and the proteasome inhibitor
bortezomib is very effective for the treatment of myeloma (Sa´n-
chez-Serrano, 2006).
Antiaging: Renovation of the Whole Organism
As autophagy has many effects on cellular renovation, it would
be reasonable to assume that autophagy can contribute to
whole-body rejuvenation. As discussed above, suppression of
autophagy causes age-dependent dysfunction in various
organs. Interestingly, many regimes that promote longevity,
including calorie restriction, TOR suppression, sirtuin activation,
and spermidine treatment, are able to induce autophagy (Madeo
et al., 2010; Rubinsztein et al., 2011). The central question is
whether this represents simply a correlation or whether auto-
phagy is indeed one of the key effectors of these regimens.
Genetic studies performed in C. elegans have shown that
some of the autophagy-related genes are required for life-span
extension induced by inhibition of insulin/IGF-like signaling and
calorie restriction (Hansen et al., 2008; Hars et al., 2007; Jia
and Levine, 2007; Mele´ndez et al., 2003; To´th et al., 2008),
although not all autophagy-related genes have a longevity-
promoting effect (Hashimoto et al., 2009). Likewise, autophagy
is also required for life-span extension induced by activation of
sirtuins (higher eukaryote homologs of the yeast NAD+-depen-
dent deacetylase Sir2) (Morselli et al., 2010), silencing of TOR
(Bjedov et al., 2010; To´th et al., 2008), spermidine treatment
(Eisenberg et al., 2009), and p53 suppression (Tavernarakis
et al., 2008). These data indicate that autophagy is a common
downstream effector in various life-prolonging signaling path-
ways. However, as other autophagy-independent pathways
are also known to be important, how much autophagy contrib-
utes overall to the longevity effects of each regimen needs
further investigation.
How can autophagy prolong life span? One obvious mecha-
nism is the cell-autonomous function of autophagy, which avoids
accumulation of toxic proteins (e.g., misfolded or aggregation-
prone proteins) and organelles (e.g., damaged mitochondria).
Additionally, autophagy could reduce inflammatory cytokine
secretion and spontaneous tumor incidence, which may also
account for its longevity-promoting effect (Madeo et al., 2010).
Conclusion
Cells routinely replace their contents to stay healthy but also to
make morphological and functional changes. In this Review,
we discussed diverse physiological and pathological processes
from the perspective of ‘‘autophagy’’ as an intracellular renova-
tion system. Such amultidisciplinary view is useful to understand
why this ‘‘self-eating’’ system has been conserved throughout
evolution, how it could participate in normal cellular regulation
as well as pathogenesis of human diseases, and how we can
take advantage of it for disease therapy. However, many funda-
mental questions remain. Even with the recent development of
sophisticated research tools, such as Cre-mediated conditional
knockout techniques, the physiological role of autophagy still
remains unknown in some key organs, such as in the bone,skin, and blood vessels. Additionally, although selective auto-
phagy substrates have been identified, the physiological
significance of degradation of each substrate, particularly of
ubiquitinated proteins, needs to be examined further.
Critical issues also remain with regard to autophagy in thera-
peutics and diagnostics. Effective indicators or biomarkers for
autophagy activity are not currently available. Such markers
are important to determine autophagic activity in the disease
setting, particularly when monitoring drug effectiveness during
autophagy-modulating therapy. Furthermore, the autophagy-
modulating drugs currently available are not strictly specific,
and the development of more specific drugs will be required.
Likewise, although the upregulation of autophagy could be theo-
retically beneficial for eliminating aggregate-prone proteins,
damaged mitochondria, and intracellular bacteria, how these
selective autophagic pathways can be stimulated is another
challenging issue. Nonetheless, the reality of autophagy-modu-
lating therapy is nowcloser thanwas ever expected or predicted.
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